Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.26.00 CHF
Change Today -1.15 / -4.24%
Volume 5.0K
NWRN On Other Exchanges
SIX Swiss Ex
As of 3:58 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Holland

Non-Executive Director and Member of R & D Committee,Newron Pharmaceuticals S.p.A.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Robert Holland, also known as Bob, has been the Chief Medical Officer of Oxford Gene Technology IP Limited since September 2013. Dr. Holland serves as Vice President of Global Experimental Medicine at AstraZeneca. Dr. Holland has an impressive clinical track record with over 25 years experience in the pharmaceutical industry, where he has contributed to the development of significant medicines in neuroscience and oncology with combined total annual sales of $8 billion. ...

Read Full Background

Corporate Headquarters*

Via Ludovico Ariosto 21
Bresso, Milan 20091


Phone: 39 026 103461
Fax: 39 02 61 03 46 54

Board Members Memberships*

Non-Executive Director and Member of R & D Committee


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NWRN:SW SFr.26.00 CHF -1.15


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEWRON PHARMACEUTICALS SPA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at